Kimberly-Clark to Acquire Kenvue
Kimberly-Clark announced it will acquire Kenvue in a cash and stock transaction valued at $48.7 billion.
The deal brings together two iconic companies that will combine their portfolios of complementary products, including 10 billion-dollar brands.
- Kenvue, a Johnson & Johnson spinoff, is the world’s largest pure-play consumer health company, with brands including:
- Aveeno
- BAND-AID Brand
- Johnson’s
- Listerine
- Neutrogena
- Tylenol
- Kimberly-Clark’s brands include:
- Huggies
- Kleenex
- Scott
- Kotex
- Cottonelle
- Poise
- Depend
- Andrex
- Pull-Ups
- Goodnites
- Intimus
- Plenitud
- Sweety
- Softex
- Viva
- WypAll
Based on current projections, the combined company would generate 2025 annual net revenues of approximately $32 billion and approximately $7 billion of adjusted EBITDA.
Author's summary: Kimberly-Clark acquires Kenvue for $48.7 billion.